Studies were carried out to determine whether or not oxygenated derivatives of cholesterol (e.g., 25-hydroxycholesterol) that specifically suppress the activity of 3-hy- 
oxidoreductase (CoA-acylating), EC 1.1.1.34], bind to a soluble component of the cytoplasm different from that which binds the nonsuppressor, cholesterol. Density gradient fractionation of the cytosolic fraction isolated from L cell cultures that had been incubated with low concentrations of 25-hydroxy [26,27- 3H]cholesterol or [1,2- 25- hydroxycholesterol. Both sterols appeared to be bound to proteins because the bound sterols were eliminated from cytosol that had been heated at 1000, and their sedimentation coefficients were altered by proteolysis. It has been established that certain derivatives of cholesterol that are produced by the introduction of a ketone or hydroxyl function in the steroid nucleus or in the side chain specifically depress the activity of the microsomal enzyme 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase [mevalonate: NADP+ oxidoreductase (CoA-acylating), EC 1.1.1.34] in cultured cells when they are added to the medium at concentrations in the range of 0.05-5 ,uM (1) (2) (3) (4) (4) . On the other hand, the suppression of HMG-CoA reductase activity in cells grown in the presence of serum or serum lipoproteins was assumed by Brown and Goldstein (6, 7) and by Kirsten and Watson (8) to be due to the cholesterol component of the lipoproteins. Weak suppression of HMG-CoA reductase activity in fibroblast cultures by relatively high levels of nonlipoprotein cholesterol has also been reported from several laboratories (1, (9) (10) (11) .
A probable explanation for these contrasting observations lies in our finding that inhibitory activity associated with commercial preparations of cholesterol, which had been recrystallized several months previously and which appeared to be pure by the usual chromatographic criteria, was in fact due to trace amounts of contaminating sterols (1) . Furthermore, the most potent known suppressors of HMG-CoA reductase activity are readily produced by autoxidation of cholesterol, a reaction that may be expected to occur when serum lipoproteins or cholesterol preparations are exposed to air or are suspended in culture medium and incubated at 370 for prolonged periods of time in the absence of an antioxidant (1-3, 12, 13) . Because the purity of the cholesterol was not established in most studies in which it appeared to be inhibitory and because the generation of cholesterol autoxidation products in the culture media was not excluded, it seems likely that the suppression of HMG-CoA reductase observed in those studies was due to compounds other than cholesterol.
If the results of our investigations with cultured cells are relevant to the regulation of cholesterol synthesis in vivo, then they imply that dietary cholesterol depresses hepatic HMG-CoA reductase activity because in the liver it is a precursor of an inhibitory sterol. They also imply that purified cholesterol did not suppress HMG-CoA reductase in the cell cultures because these cells did not metabolize it to any inhibitory sterol, which is consistent with what is presently known in this regard (3) . The probability that oxygenated sterols-either precursors of cholesterol or products of its metabolism-function as regulators of sterol synthesis in vivo is enhanced by the observation that hydroxylated cholesterol derivatives suppress cholesterogenesis in rapidly proliferating intestinal crypt cells very effectively when they are administered orally to mice, whereas cholesterol does not (14) . Intracellular synthesis of a regulatory sterol other than cholesterol seems to be a reasonable explanation for the cycle of sterol synthesis observed in lectin-stimulated lymphocytes cultered in medium containing lipoprotein cholesterol or cholesterol suspended with albumin (15) .
The mechanism by which the cholesterol derivatives suppress HMG-CoA reductase activity has not been determined. Diurnal alterations in hepatic HMG-CoA reductase activity and induction of the enzyme activity by cholestyramine feeding or by injecting Triton WR 1339 involve alterations in the rate of enzyme synthesis (16) (17) (18) (19) . On the other hand, dietary cholesterol may result in inactivation of the enzyme as well as suppression of its synthesis (20) . Because inhibitory sterols do not affect HMG-CoA reductase activity directly-i.e., when they are added to an enzyme reaction mixture (1-3)-it seems likely that they repress the synthesis of the enzyme or else they inactivate it through some indirect mechanism as has been suggested by Bell et al. (10) .
It is reasonable to postulate that (i) either of the above mechanisms for suppressing HMG-CoA reductase activity involves the specific binding of the inhibitory sterol to some intracellular component other than the enzyme itself, and (ii) cholesterol, which is not inhibitory, either will not bind to the same component or will bind to it with lower affinity than does the inhibitory sterol. Previously reported evidence for the dif- 1A) . In contrast to the results obtained with 25-hydroxycholesterol, cholesterol was widely distributed throughout the lower three-fourths of the gradient, usually as two or more broad, overlapping bands-the highest concentration of the sterol being near the bottom of the gradient (Fig. 1B) . The approximate sedimentation coefficient calculated for the major band of bound cholesterol was 21 S and sedimentation coefficients for minor bands ranged between 4 S and 9 S (see Figs. 1-3 Fig. 1 (Fig. 2A) . After digestion with protease, the 21S band of bound cholesterol was diminished and new bands of lower density appeared (Fig. 2B) .
The characteristic banding pattern of bound 25-hydroxycholesterol found when L cells were incubated with low concentrations of the labeled sterol was also markedly altered when the cells were preincubated with relatively high concentrations, 5 ,ug/ml (12.5 ,M) or higher, of unlabeled 25-hydroxycholesterol (Fig. 3A) . The major (8S) band was greatly diminished whereas the smaller 5S band remained unaltered. Diminution of the 8S band, similar to that indicated by the broken line in Fig. 3A (20 jig/ml) of unlabeled cholesterol or 25-hydroxycholesterol ( Fig. 3 B and D (1977) tosolic proteins, the greatest proportion of which exhibited a sedimentation coefficient of about 5 S. The protein nature of the cytosolic components in both the 5S and 8S bands is indicated by their lability to heat. Furthermore, the 8S band was eliminated by proteolysis. The nature of the change in the banding pattern of the 25-hydroxycholesterol-protein complexes, brought about by preincubating the cells with high levels of unlabeled 25-hydroxycholesterol, was not established by the present studies. The unlabeled sterol may have saturated the 8S protein so that 25-hydroxy[3H]cholesterol taken up subsequently may have been unable to bind to it. Alternatively, the unlabeled sterolprotein complexes may have aggregated or may have become bound to nuclear or other particulate components of the cell so that they were not recovered with the cytosol.
The banding pattern of bound cholesterol varied somewhat from experiment to experiment. The lability of the bands to heat and the effect upon them of proteolysis indicated that they included protein. However, the results obtained did not show that the cholesterol binding sites were saturable because the banding pattern for [3H]cholesterol was only slightly altered by preincubating the cells with high concentrations of cholesterol. We have shown previously (3, 4) that the uptake of cholesterol by L cells is limited and it is possible that intracellular concentrations of the unlabeled sterol did not become high enough during the preincubation period to saturate the protein to which [3H]cholesterol was subsequently bound. Presumably, the proteins present in some, or in all, of the bands of cholesterol-protein complex represent sterol-binding proteins that have already been studied by other investigators using procedures other than those described herein. The "sterol-carrier protein" described by Dempsey (23) has been characterized as a polypeptide, of molecular weight 16,000, which forms large aggregates when cholesterol or other related monohydroxysterols are bound to it and which functions as a carrier in the terminal stages of steroid biosynthesis. Another protein which has been labeled "sterol-carrier protein," by Scallen et al. (24) functions as a carrier protein in the squalene epoxidase reaction (25) . It binds squalene but appears not to be an effective carrier for sterols (26) .
We have characterized the 25-hydroxycholesterol-and cholesterol-binding proteins further in many studies in which the sterols were incubated with isolated L-cell cytosol at 00 [conditions similar to those commonly used to investigate the binding of steroid hormones to cytoplasmic receptors (27)] before they were fractionated by density gradient centrifugation. These studies provide further evidence for the presence of separate binding proteins for the two sterols and illustrate clearly that relatively low molecular weight proteins that bind cholesterol are present in the cytosol and that they aggregate when the concentration of cholesterol in the incubation mixture is increased. However, the possibility that nonspecific associations between sterols and proteins may develop is much greater under these conditions than when the sterols are taken up by live cells, and these results require a more cautious analysis than those presented herein.
The binding of 25-hydroxycholesterol and cholesterol to cytosolic components in long-term cultures of fetal mouse liver cells has also been investigated. Under conditions similar to those shown in Figs. 1 and 3 , the results obtained with the liver cells were in close agreement with those shown for L cells, indicating that the binding proteins were present in more than one cell type.
Studies of cellular sterol-binding proteins and of their functions are still in an early stage and only tentative conclusions can be drawn from the results presented in this report. However, the evidence for a protein with specificity for sterols that suppress HMG-CoA reductase represents a significant step toward elucidation of the mechanism through which cholesterol synthesis is regulated. Also by demonstrating a cellular means for distinguishing between inhibitory and noninhibitory sterols, it provides support for the hypothesis that regulation of HMG-CoA reductase is accomplished by sterols other than cholesterol.
